Cardiol Therapeutics Inc. Class A Common Shares (CRDL) is a publicly traded Healthcare sector company. As of September 9, 2026, CRDL trades at $2.31 with a market cap of $259.35M and a P/E ratio of 0.00. CRDL moved +3.15% today. Year to date, CRDL is +132.75%; over the trailing twelve months it is +111.43%. Its 52-week range spans $0.77 to $2.28. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces CRDL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CRDL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CRDL recently traded at $2.31. Market cap is $259.35M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $2.31 |
| Market Cap | $259.35M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.28 |
| 52-Week Low | $0.77 |
| Volume | 1.92M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover CRDL: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.